EP4 receptor antagonist 7, CAS [[3035217-40-1]] Preis auf Anfrage
Artikelnummer:
TGM-T204782
Hersteller Artikelnummer:
T204782
Alternativnummer:
TGM-T204782-10MG,TGM-T204782-50MG
Hersteller:
TargetMol
Kategorie:
Biochemikalien
EP4 receptor antagonist 7 (Compound 14) is an antagonist of the prostaglandin E2 (PGE2) receptor subtype EP4, with an IC50 of 1.1 nM. This compound inhibits PGE2-induced beta-arrestin recruitment in HEK293 cells with an IC50 of 0.9 nM. In RAW 264.7 macrophages, it reduces the expression of PGE2-induced IL-4, macrophage mannose receptor 1 (Mrc1), chitinase-like protein 3 (Chil3), chemokine (C-X-C motif) ligand 1 (Cxcl1), triggering receptor expressed on myeloid cells 2 (Trem2), and arginase 1 (Arg1) mRNA. In the CT26 mouse colon cancer model, EP4 receptor antagonist 7, combined with an anti-PD-1 antibody, inhibits tumor growth and enhances CD8+ T cell infiltration into the tumor.
Molekulargewicht:
453.413
CAS Nummer:
[3035217-40-1]
Formel:
C24H18F3N3O3
Target-Kategorie:
Interleukin|||Prostaglandin Receptor
T204782
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten